Literature DB >> 3943188

Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma.

J E Groener, R W Pelton, G M Kostner.   

Abstract

This simple, routine assay for measuring cholesteryl ester transfer/exchange activity in human plasma is based on the removal of interfering lipoproteins--very-low-density (VLDL) and low-density lipoproteins (LDL)--by precipitation with polyethylene glycol. High-density lipoproteins (HDL) in the samples do not affect the results. The supernate after precipitation is mixed with [14C]cholesteryl ester-labeled LDL as donor and with HDL as the acceptor for the cholesteryl ester. After incubation for 16 h at 37 degrees C, LDL is separated from HDL by precipitation with dextran sulfate and the radioactivity measured in the supernate, which contains the HDL. The assay is applicable to samples containing as much as 10 mmol of triglycerides per liter. The within-assay CV was 2.7%, the day-to-day CV 6.8%. Results compared well with those by conventional procedures.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3943188

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  21 in total

1.  Raman imaging of macrophages incubated with triglyceride-enriched oxLDL visualizes translocation of lipids between endocytic vesicles and lipid droplets.

Authors:  Clara Stiebing; Lisa Schmölz; Maria Wallert; Christian Matthäus; Stefan Lorkowski; Jürgen Popp
Journal:  J Lipid Res       Date:  2017-01-31       Impact factor: 5.922

2.  Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol.

Authors:  Laxman Yetukuri; Sanni Söderlund; Artturi Koivuniemi; Tuulikki Seppänen-Laakso; Perttu S Niemelä; Marja Hyvönen; Marja-Riitta Taskinen; Ilpo Vattulainen; Matti Jauhiainen; Matej Oresic
Journal:  J Lipid Res       Date:  2010-04-29       Impact factor: 5.922

3.  Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.

Authors:  E Tahvanainen; M Syvanne; M H Frick; S Murtomaki-Repo; M Antikainen; Y A Kesaniemi; H Kauma; A Pasternak; M R Taskinen; C Ehnholm
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

4.  Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides.

Authors:  S Lahdenperä; M Syvänne; J Kahri; M R Taskinen
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

5.  Increased cholesterylester transfer activity in complicated type 1 (insulin-dependent) diabetes mellitus--its relationship with serum lipids.

Authors:  R P Dullaart; J E Groener; L D Dikkeschei; D W Erkelens; H Doorenbos
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

6.  A 31P nuclear magnetic resonance investigation of acyl group transfer from phosphatidylcholine to yield lysophosphatidylcholine in human plasma.

Authors:  M H Nouri-Sorkhabi; D R Sullivan; D C Roberts; P W Kuchel
Journal:  Lipids       Date:  1994-03       Impact factor: 1.880

7.  Fenofibrate improves postprandial chylomicron clearance in II B hyperlipoproteinemia.

Authors:  B Föger; H Drexel; T Hopferwieser; G Miesenböck; A Ritsch; M Lechleitner; G Tröbinger; J R Patsch
Journal:  Clin Investig       Date:  1994-03

8.  A hyperalphalipoproteinaemic family with normal cholesteryl ester transfer/exchange activity.

Authors:  J E Groener; P G da Col; G M Kostner
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

9.  Plasma activities of lecithin:cholesterol acyltransferase, lipid transfer proteins and post-heparin lipases in inbred strains of rabbits hypo- or hyper-responsive to dietary cholesterol.

Authors:  G W Meijer; P N Demacker; A Van Tol; J E Groener; J G Van der Palen; A F Stalenhoef; L M Van Zutphen; A C Beynen
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

10.  Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities.

Authors:  G Miesenböck; B Hölzl; B Föger; E Brandstätter; B Paulweber; F Sandhofer; J R Patsch
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.